- Home
- PHAT vs BH Comparison
PHAT vs BH Comparison
Compare PHAT & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAT | BH |
|---|---|---|
| Founded | 2018 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.6M | 944.3M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | PHAT | BH |
|---|---|---|
| Price | $14.36 | $320.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.33 | N/A |
| AVG Volume (30 Days) | ★ 828.8K | 119.2K |
| Earning Date | 10-30-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.91 |
| Revenue | $147,190,000.00 | ★ $386,507,000.00 |
| Revenue This Year | $218.59 | N/A |
| Revenue Next Year | $84.38 | N/A |
| P/E Ratio | ★ N/A | $471.61 |
| Revenue Growth | ★ 460.30 | 6.87 |
| 52 Week Low | $2.21 | $195.05 |
| 52 Week High | $16.27 | $381.83 |
Technical Indicators
Market Signals| Indicator | PHAT | BH |
|---|---|---|
| Relative Strength Index (RSI) | 49.05 | 53.97 |
| Support Level | $14.12 | $300.97 |
| Resistance Level | $16.27 | $324.20 |
| Average True Range (ATR) | 0.72 | 15.59 |
| MACD | -0.12 | 3.85 |
| Stochastic Oscillator | 8.39 | 97.64 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.